Skip to content

Clinical trials

Phase 2 Autism Spectrum Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 2 Country / region: United States Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20072
20081
20092
20103
20115
20128
20136
20146
20153
20166
20173
20188
20195
20208
20217
20224
20238
20244
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Recruiting15
Terminated12
Active, not recruiting9
Withdrawn7
Not yet recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University8
Massachusetts General Hospital4
National Institute of Mental Health (NIMH)4
Southwest Autism Research & Resource Center4
Forest Laboratories3
Hoffmann-La Roche3
Jazz Pharmaceuticals3
Seaside Therapeutics, Inc.3
Arizona State University2
Emory University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder101
Autistic Disorder48
Asperger Syndrome9
Anxiety Disorders7
Child Development Disorders, Pervasive6
Developmental Disabilities3
Language Disorders3
Constipation2
Diarrhea2
Digestive System Diseases2

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.